CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma
Journal of Cutaneous Pathology · 2025-05 · 52 (5) · 379-383
DOI: 10.1111/cup.14790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 03.03.2025. Verfasst von Sarah Williamson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, MetroHealth Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neurothekeoma, Skin Neoplasms, Syndecan-1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Background
We incidentally observed CD138 (syndecan‐1) expression in a cellular neurothekeoma (CNT) and sought to investigate whether this is a consistent finding in these tumors.
Methods
We evaluated a series of 20 skin biopsy specimens diagnosed as CNT for CD138 immunohistochemical staining in comparison to the more traditional CNT immunohistochemical stains, NKI/C3 and MITF. Control cases of xanthogranuloma (XG), dermal Spitz nevi, and epithelioid fibrous histiocytomas (EFH) were included based on similar histopathologic morphology.
Results
CD138 expression in a membranous and reticulated extracellular pattern was observed in 95% of CNT cases evaluated. NKI/C3 was expressed in 83% of CNT, and MITF in 72%. Of the control cases, 10% of XG, 10% of dermal Spitz nevi, and 17% of EFH expressed CD138.
Conclusions
Our data suggest that CD138 may be a useful adjunctive marker in the diagnosis of CNT, particularly when utilized in a panel with other established markers such as NKI/C3 and MITF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, MetroHealth Medical Center, Cleveland, Ohio, USA.
- Department of Pathology, MetroHealth Medical Center, Cleveland, Ohio, USA.
ORCID-Profile: Sarah Williamson
Zitieren
APA
Williamson, S., Rosenberg, A., Jassim, S., & Somach, S. (2025). CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma. Journal of Cutaneous Pathology, 52(5), 379-383. https://doi.org/10.1111/cup.14790
Vancouver
Williamson S, Rosenberg A, Jassim S, Somach S. CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma. Journal of Cutaneous Pathology. 2025;52(5):379-383. doi:10.1111/cup.14790
BibTeX
@article{Williamson2025,
author = {Williamson, Sarah and Rosenberg, Arlene and Jassim, Sarmad and Somach, Stephen},
title = {CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma},
journal = {Journal of Cutaneous Pathology},
year = {2025},
volume = {52},
number = {5},
pages = {379--383},
doi = {10.1111/cup.14790}
}
EUVIMED